logo

Last Update

This profile was last updated on 3/14/2017 and contains contributions from the  Zoominfo Community.

is this you? Claim your profile.

Wrong Alan Moy?

Alan B. Moy

President and Co-Founder

Cellular Engineering Technologies Inc.

HQ Phone:  (319) 665-3000

Direct Phone: (319) ***-****direct phone

Email: m***@***.com

GET ZOOMINFO GROW

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions.

I agree to the  Terms of Service and  Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

THANK YOU FOR DOWNLOADING!

computers
  • 1.Download
    ZoomInfo Grow
    v sign
  • 2.Run Installation
    Wizard
  • 3.Check your inbox to
    Sign in to ZoomInfo Grow

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Community Edition at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

Cellular Engineering Technologies Inc.

2500 Crosspark Rd

Coralville, Iowa,52241

United States

Company Description

CET specializes in stem cell research, tissue engineering and cancer biology. We develop media, provide and conduct research on stem cells obtained from human non-embryonic sources, such as adipose tissue, bone marrow, Wharton's jelly, umbilical cord blood, an...more

Background Information

Employment History

Director

John Paul II Stem Cell Research Institute


Creighton University


Adjunct Professor of College of Engineering

University of Iowa


Pulmonologist

Mercy Hospital


Affiliations

CET

Founder


Pulmonary Associates of Iowa City Inc

Founder


JP2MRI

Founder


Education

M.D.

Creighton


bachelor's degree

biochemistry

University of California , Davis


degree

biochemistry

University of California at Davis


Web References(77 Total References)


Act NOW! Saturday's Midwest March for Life tickets are going FAST! | Iowa Right to Life

www.iowartl.org [cached]

Dr. Alan Moy , Founder/President, Cellular Engineering Technologies, Inc.; President/Scientific Director, John Paul II Medical Research Institute
Filed Under: EventsTagged With: Abortion Survivors Network, Archbishop Jackels, Bishop Pates, Dr. Alan Moy, Dr. Karla Polaschek, Governor Branstad, Iowa Catholic Conference, Iowa Right to Life, Janet Huckabee, Jenifer Bowen, John Paul II Medical Research Institute, Lt.


Growing Ethical Stem Cell Research in Iowa | Iowa Right to Life

www.iowartl.org [cached]

Dr. Alan Moy, MD, is founder of the John Paul II Stem Cell Research Institute (JP2SRI), which focuses on adult and cord blood research and education.
JP2SRI's mission is to advance research and education on stem cells in a manner consistent with pro-life bioethics. The Institute was named for Pope John Paul II, who called for a "Culture of Life" and maintained that advances in science and biotechnology must never ignore the dignity of the human person. Dr. Moy has serious credentials. He is a practicing physician, in addition to being a physician-scientist. His previous academic appointments include the University of Iowa College of Medicine and the College of Engineering, where he is currently an Adjunct Associate Professor. He is also founder and president of Cellular Engineering Technologies Inc., an Iowa based biotech company.


The John Paul II Stem Cell Research Institute - Board Members

jp2sri.org [cached]

Alan Moy MD. Scientific Director of John Paul II Stem Cell Research Institute, CEO, Cellular Engineering Technologies, Inc, Adjunct Associate Professor, College of Engineering, University of Iowa


Stem cells: JP2MRI, CET discover safer, more ethical biotechnology | Catholic Globe

www.catholicglobe.org [cached]

The John Paul II Medical Research Institute (JP2MRI), a non-profit of Iowa City, was founded by Dr. Alan Moy in 2007 to address a shortcoming when it came to pro-life values being upheld concerning a variety of medical practices and issues.
The doctor also is co-founder and CEO of Cellular Engineering Technologies (CET), a for-profit biotechnology company that manufactures commercial adult stem cells and other biotechnology products. He explained that JP2MRI was founded a year after starting CET to advance the application of adult stem technology to clinical applications in the area of neurodegenerative disease, rare disease, cancer and chronic diseases of unmet needs or in underperformed diseased areas. His concern was that the United States was falling behind other countries in the area of adult stem cell research. Recently, through collaborative research by JP2MRI and CET, a new method for creating safer induced pluripotent stem cells, or iPSC, for clinical use was discovered. "We started work in traditional adult stem cells over a decade ago," Moy explained. Most embryonic stem cells and iPS cells have the risk of causing tumors because of their genetic instability," Moy said. "What we worked on was trying to reduce the tumor risk." Building on the original iPSC technology, JP2MRI and CET developed a method by using a variety of chemicals to replace known cancer-causing genes in the process. "Now we have an iPS technology that is safer," said Moy, who noted an added benefit is potential reduced cost in drug development. Potential applications He spoke about practical applications of this technology such as expanding the use of stored cord blood stem cells for future medical treatment if a disease develops in the child. "We have a means where we can take the cord blood and make an iPS cell which can have lifelong utility and diversity," Moy added. For those who do not have stored cord blood, he said all is not lost as blood can be drawn and stored for people to create their own iPS cell for future use. Moy anticipates there will increasingly be a movement to shift toward human cell manufacturing, "and if we don't come up with non-controversial human cells, we are going to have a lot of controversial human protein therapeutics, gene therapies and vaccines that will be distributed at hospitals that must be administered by doctors." "We have to have alternative products that are equal or better than the products that are currently out there," said Moy. The Catholic Church, as well as the average person, may not always be aware of the unethical nature of many of these products. Moy said he has been trying to communicate areas of concern to the Catholic community for years. "The evolution of biotechnology over decades has become secularized and the power is in the secularists," he said. Advancement of illicit-cell treatment and therapy "is a serious potential threat to the Catholic health care system including Catholic hospitals and Catholics who are healthcare providers." Moy feels strongly about Catholics and the church being pro-active in the bioethics arena. "The only way in which we can influence the biotechnology field is through innovation," he said. Moy said they are not only looking for ways to produce a variety of products using the safer iPS cells, but plan to license them so other scientists, companies and industries can take advantage of these cells to pursue more ethical biotechnology. Tags:Dr. Alan Moy, ethics in biotechnology, John Paul II Medical Research Institute, JP2MRI, Renee Webb, safer iPS cells


Pulmonary Associates of Iowa City - Alan Moy

www.paiowacity.com [cached]

Alan Moy MD, FCCP
Medical Education: Creighton University


Similar Profiles

city

Browse ZoomInfo's Business
Contact Directory by City

city

Browse ZoomInfo's
Business People Directory

city

Browse ZoomInfo's
Advanced Company Directory